AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake City — South Salt Lake, Utah

AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake City is a clinical research site located in South Salt Lake, Utah, United States 84106-1466.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake City has participated in 1 clinical trials.

Therapeutic areas: SARS-CoV-2, Influenza.

Sponsors: ModernaTX, Inc..

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in South Salt Lake

Browse all research sites in Utah · View every site in South Salt Lake

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake City?

AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake City has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake City conducted?

AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake City has 1 clinical trials on record. Their work covers SARS-CoV-2, Influenza.

Is AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake City accredited by Crixeo Clinical Trials?

AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake City has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AES - DRS - Synexus Clinical Research US, Inc. - Salt Lake City?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.